News for Nevro Corp. (NVRO)

Published at

May 27, 2025 5:30 PM

by gurufocus.com

positive

positive

Zimmer Biomet Holdings (ZBH) Appoints Kevin Thornal as Group President

Zimmer Biomet Holdings, Inc. (ZBH) has announced the appointment of Kevin Thornal to the newly-created position of Group President, Global Businesses and the

ZIM.DE ZBH.MX ZBH NVRO HOLX.MX HOLX HO1.DE H1OL34.SA GMED.MX GMED 0J5Q.L

Read more →
Published at

May 27, 2025 3:00 PM

by gurufocus.com

mixed

mixed

Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas

PR NewswireWARSAW, Ind., May 27, 2025 WARSAW, Ind., May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technol

ZIM.DE ZBH.MX ZBH NVRO HOLX.MX HOLX HO1.DE H1OL34.SA 0J5Q.L SYK

Read more →
Published at

May 27, 2025 2:47 PM

by gurufocus.com

positive

positive

Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas | ZBH Stock News

Zimmer Biomet (ZBH) appoints Kevin Thornal as Group President for Global Businesses and the Americas, effective July 1, 2025. Thornal brings over 20 yea

ZIM.DE ZBH.MX ZBH NVRO HOLX.MX HOLX HO1.DE H1OL34.SA 0J5Q.L

Read more →
Published at

May 19, 2025 4:17 PM

by manilatimes.net

mixed

mixed

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

**media[630531,630532]**

NVRO MLSS BMY SYK STJ

Read more →
Published at

May 16, 2025 12:06 AM

by gurufocus.com

positive

positive

Globus Medical Announces $500 Million Share Repurchase Program | GMED Stock News

Globus Medical (GMED) has authorized a $500 million share repurchase program, funded through existing cash reserves. The program is open-ended with repu

NVRO GMED.MX GMED

Read more →
Published at

May 15, 2025 10:50 PM

by manilatimes.net

positive

positive

Globus Medical Announces $500 Million Share Repurchase Program

**media[627627]**

NVRO GMED.MX GMED

Read more →
Published at

May 14, 2025 4:37 PM

by gurufocus.com

mixed

mixed

Outset Medical (OM) Welcomes Kevin O'Boyle to Board, Dale E. Jones Steps Down | OM Stock News

Outset Medical (OM) has announced a significant change to its Board of Directors with the appointment of Kevin O'Boyle, a seasoned professional in the healthcar

OM NVRO GMED.MX GMED

Read more →
Published at

May 14, 2025 4:00 PM

by gurufocus.com

mixed

mixed

Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors

SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. ( OM) (”Outset”), a medical technology company pioneering a first-of-its-kind tech

SIEN OM NVRO NUVA.MX NUVA GMED.MX GMED

Read more →
Published at

May 14, 2025 3:31 PM

by manilatimes.net

mixed

mixed

Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors

**media[625683]**

SIEN OM NVRO NUVA.MX NUVA GNMK GMED.MX GMED

Read more →
Published at

May 9, 2025 12:00 AM

by gurufocus.com

mixed

mixed

Arcellx Provides First Quarter 2025 Financial Results and Business Highlights

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer a

NVRO OOMA CORT 0I3Q.L

Read more →
Published at

Apr 7, 2025 2:37 PM

by zacks.com

positive

positive

GMED Stock May Benefit Following the Acquisition of Nevro

Globus Medical acquires Nevro Corp. to expand its presence in the $2.50 billion musculoskeletal market.

NVRO

Read more →
Published at

Apr 3, 2025 4:05 PM

by gurufocus.com

positive

positive

Globus Medical Inc (GMED) Completes Acquisition of Nevro Corp, Expanding Market Opportunities

On April 3, 2025, Globus Medical Inc (GMED), a prominent musculoskeletal technology company, announced the successful completion of its acquisition of Nevro Cor

NVRO GMED.MX GMED

Read more →
Published at

Apr 3, 2025 2:31 PM

by markets.businessinsider.com

mixed

mixed

Globus Medical completes acquisition of Nevro Corp.

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announce...

MSCL.SN NVRO GMED.MX GMED

Read more →
Published at

Mar 24, 2025 12:00 AM

by gurufocus.com

positive

positive

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, NVRO, PLYA on Behalf of Shareholders

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

PLYA NVRO H

Read more →
Published at

Mar 22, 2025 12:06 AM

by gurufocus.com

neutral

neutral

Arcellx Inc (ACLX) Strengthens Board with Strategic Appointments

Arcellx Inc (ACLX), a biotechnology firm focused on developing innovative immunotherapies for cancer and other incurable diseases, announced the appointment of

NVRO

Read more →
Published at

Mar 21, 2025 4:26 PM

by gurufocus.com

positive

positive

Beryl Capital Management LLC Acquires Significant Stake in Nevro Corp

On March 3, 2025, Beryl Capital Management LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 2,444,319 shares of Nevro Corp (NVRO) at a pri

RVNC NVRO BCOV

Read more →
Published at

Mar 20, 2025 11:00 PM

by gurufocus.com

mixed

mixed

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer a

NVRO OOMA CORT 0I3Q.L

Read more →
Published at

Mar 19, 2025 4:32 PM

by zacks.com

neutral

neutral

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

NVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 results amid a weak SCS market.

NVRO

Read more →
Published at

Mar 5, 2025 5:38 PM

by zacks.com

negative

negative

Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down

NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The company continues to incur losses at the operating level.

NVRO

Read more →
Published at

Mar 4, 2025 11:45 PM

by zacks.com

positive

positive

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 18.99% and 1.49%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

NVRO

Read more →